+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2



Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2



International Journal of Clinical and Laboratory Research 26(3): 207-210



It is thought that Helicobacter pylori colonization of the gastric mucosa might stimulate the production of several cytokines, which might trigger and maintain the gastric inflammation associated with Helicobacter pylori infection. In the present study we evaluated interleukin-1 beta. interleukin-6, and the soluble receptor of interleukin-2 both in mucosal homogenates and in the sera of Helicobacter pylori-infected (39 cases) and uninfected (40 cases) patients to investigate whether there was any relationship between variations in cytokines and (1) the severity of Helicobacter pylori-associated gastritis or (2) CagA-positive Helicobacter pylori strains. Mucosal, but not serum levels of interleukins-1 and -6 and interleukin-2 receptor were significantly higher in infected than uninfected patients. Serum levels of Helicobacter pylori antibodies were significantly higher in infected than uninfected patients. These levels correlated with mucosal interleukin-1 beta. The degree of antral or body inflammatory grade was higher in infected than in uninfected patients; cytokines levels were higher in patients with high-grade gastritis, most of whom were Helicobacter pylori positive. Patients infected with CagA-positive strains also had higher levels of interleukin-1 beta, but not of interleukin-2 receptor or interleukin-6. In conclusion. Helicobacter pylori infection results in a local increase in interleukins-1 beta and -6 and interleukin-2 receptor associated with high-grade mucosal inflammation. Interleukin-1 beta seems to favor anti-Helicobacter pylori antibody production, and mucosal levels are enhanced mainly in patients infected with cytotoxic Helicobacter pylori strains.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 046230169

Download citation: RISBibTeXText

PMID: 8905454


Related references

Helicobacter pylori infection enhances mucosal interleukin-1β, interleukin-6, and the soluble receptor of interleukin-2. International Journal of Clinical and Laboratory Research 26(3): 207-210, 1996

Topical duodenal and gastric mucosal production of interleukin-1 beta, interleukin-6, interleukin-8, tumor necrosis factor alfa and interleukin-2-soluble receptor in Helicobacter pylori positive and negative patients A pilot study. Gut 39(Suppl. 2): A39-A40, 1996

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scandinavian Journal of Gastroenterology 29(5): 425-429, 1994

Evidence for interleukin-1-independent stimulation of interleukin-12 and down-regulation by interleukin-10 in Helicobacter pylori-infected murine dendritic cells deficient in the interleukin-1 receptor. Fems Immunology and Medical Microbiology 47(3): 414-419, 2006

Association of mucosal levels of interleukin 10 and interleukin 8 in patients with Helicobacter pylori infection. Gastroenterology 114(4 Part 2): A1123, 1998

Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123(6): 1793-1803, 2002

Mucosal Tumor Necrosis Factor-or, Interleukin-1/3, and Interleukin-8 Production in Patients with Helicobacter pylori Infection. Scandinavian Journal of Gastroenterology 29(5): 425-429, 1994

Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome. Leukemia and Lymphoma 47(4): 603-611, 2006

Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 33(1): 55-58, 1992

Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis rapid induction of tumor necrosis factor alpha interleukin 1 beta interleukin 6 gamma interferon and soluble interleukin 2 receptor m r 55000 protein. Cancer Research 52(5): 1123-1128, 1992

Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. European Journal of Obstetrics and Gynecology and Reproductive Biology 87(1): 81-85, 1999

Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics 99(3): 276-284, 2005

Interleukin-1 beta differentially affects interleukin-6 and soluble interleukin-6 receptor in the blood and central nervous system of the monkey. Journal of Neuroimmunology 66(1-2): 135-141, 1996

Differential normalization of mucosal interleukin-8 and interleukin-6 activity after Helicobacter pylori eradication. Infection and Immunity 66(10): 4742-4747, 1998

Cytokines and malaria. Study of tumour necrosis factor alpha, interleukin 1 beta, interleukin 6 and of the soluble interleukin 2 receptor in 28 patients. Bulletin de la Societe de Pathologie Exotique 87(2): 91-96, 1994